Related Experiment Videos

Menopausal changes in the myometrium: an investigation using a GnRH agonist model

A D Weeks1, N Wilkinson, D S Arora

  • 1Department of Obstetrics and Gynecology, St James's University Hospital, Leeds, United Kingdom.

Summary

Leuprolide acetate (a gonadotropin-releasing hormone agonist) reduces uterine vascularity and causes myometrial changes. This treatment leads to hypoestrinism, resulting in myocyte atrophy and arterial wall alterations in premenopausal women.

Related Concept Videos